Further analysis with the use of another oncogenomic tool, PPISURV [45], showed that the increased expression of DROSHA generally (across cancers/datasets) correlates with decreased survival (Figure 6B and Supplementary Figure S2). The gene discussed is DROSHA; the disease is cancer.